Impact Fusion International
Revolutionary Cattle Feed Technology
Why Is a Company With 85% Cost-Saving Technology Trading at Just $19M Market Cap?
Ticker: IFUS (OTC)
Price: $0.0340 (December 13, 2025)
Shares Outstanding: 560.5 million
Float (DTC): 292 million
Market Cap: $19.8 million
52-Week Range: $0.0238 - $0.121
Executive Summary: Impact Fusion International (OTC: IFUS) represents an extraordinary asymmetric opportunity in agricultural biotechnology that institutional investors have completely overlooked.
The Company:
- Developed SGP+ (Supreme Gold Plus) - revolutionary cattle feed made from sugarcane bagasse waste
- Customers report up to 85% reduction in feed costs ($3.45 to $0.45 per head/day)
- Addresses critical industry challenges: feed costs, environmental impact (methane reduction, fly elimination), and herd health
- Production capacity of 4,900 tons/week = $38.2M annual revenue potential at $150/ton
Scientific & Government Validation:
- Partnership with Southern University Agricultural Research Center (SUARC)
- Louisiana Legislature unanimous support - HCR-42 passed 99-0 (House) and 31-0 (Senate)
- Dr. Bagley (43 years research) calls SGP+ the "Holy Grail" of unlocking lignin energy
- Multiple field trials with Texas ranchers showing consistent results
The Valuation Disconnect:
- Total Debt: Only $640,830 - minimal debt with patient capital backing
- Market Cap: $19.8 million
Multiple Catalysts:
- India Expansion: Discussions with partners controlling 500,000+ dairy cattle and 10 sugar refineries
- Multiple Revenue Streams: Cattle feed, Nutri-Mastic health products, AIT (patent-pending artificial insemination technology)
- Market Timing: U.S. cattle inventory at decades-low, drought conditions creating urgent demand for alternative feeds
The Bottom Line: IFUS sits at the intersection of sustainability and profitability. The market is pricing the company as if the technology doesn't work. If even partial execution occurs, substantial re-rating is inevitable.
This is a comprehensive investment analysis based on company filings, public disclosures, and independent research. Read the full disclaimer at the bottom.
Jump to section: Snapshot | The Technology | The Assets | Financials | Market Opportunity | Investment Thesis | Risks
Investment Snapshot
COMPANY VITALS (As of December 13, 2025):
- Company Name: Impact Fusion International, Inc.
- Ticker Symbol: OTC: IFUS
- Stock Price: $0.0340 (down 12.14% over 10 days)
- Shares Outstanding: 560.5 million
- Market Cap: $19.8 million
- EPS (TTM): -$0.01
- Total Cash: $15,020
- Total Debt: $640,830 (significantly reduced from prior years)
- Employees: 4
- Current Revenue: Early commercialization phase
- Headquarters: Napoleonville, Louisiana
THE CORE INVESTMENT CASE:
- Disruptive Technology: Proprietary lignin depolymerization process unlocks previously indigestible agricultural waste
- Massive Cost Savings: Customers report up to 85% reduction in feed costs ($3.45 to $0.45 per head/day)
- Scientific Validation: Southern University Agricultural Research Center (SUARC) partnership, Louisiana Legislature unanimous support (HCR-42)
- Environmental Benefits: Reduces methane emissions, eliminates flies (up to 100% in 16-20 days), improves manure quality
- Market Timing: U.S. cattle inventory at decades-low, drought conditions driving demand for alternative feeds
- Multiple Revenue Streams: Cattle feed, Nutri-Mastic health products, artificial insemination technology (AIT patent pending)
- International Expansion: India discussions with partners controlling 500,000+ dairy cattle
Get More Stock Research
Receive stock alerts and deep-dive reports delivered to your inbox.
No spam. Unsubscribe anytime.
Leadership: Small Team, Big Vision
Marc Walther - President & CEO
The driving force behind Impact Fusion's transformation is CEO Marc Walther, who brings entrepreneurial energy and deep connections to the agricultural industry. His approach mirrors sovereign wealth fund discipline despite operating in the OTC markets.
LEADERSHIP CHARACTERISTICS:
1. HANDS-ON OPERATOR
Walther personally donated 2 truckloads of SGP+ to Texas ranchers affected by the 2024 Smokehouse Creek wildfire, generating media attention and customer acquisition across multiple states (Ohio, Illinois, Kansas, Texas, Oklahoma).
2. INDUSTRY ENGAGEMENT
Active participant in agricultural symposiums, trade shows, and podcasts. Conducted 90-minute interview with Buffalo Fireside Chats discussing all aspects of Impact Fusion's technology and vision.
3. INNOVATION FOCUS
Filed patent-pending for AIT (Artificial Insemination Technology) for mammals in October 2025. Expanding IP portfolio beyond cattle feed into broader agricultural solutions.
Supporting Team
- Robert (Trey) Schmidt III: Appointed April 2024 to strengthen operational capabilities
- Dr. Bagley (SUARC Partner): 43 years research experience, testified to Louisiana Legislature that SGP+ is the "Holy Grail" of unlocking lignin energy
- Total Staff: 4 employees (lean operation focused on technology development and partnerships)
Strategic Partnerships
| Partner | Role | Significance |
|---|---|---|
| Southern University (SUARC) | Research Validation | 3-month study on SGP+ effectiveness, academic credibility |
| Louisiana Legislature | Government Support | HCR-42 passed 99-0 (House) and 31-0 (Senate) supporting bagasse utilization |
| Texas A&M University | Field Testing | Deer Run Ranch participating in USDA Manure Study |
| Indian Partners | International Expansion | Control 10 sugar refineries, 500,000+ dairy cattle access |
| AgriGlow BioTech | Market Entry | Facilitating India market development |
The Technology: What Makes SGP+ Revolutionary
The Lignin Breakthrough
For decades, agricultural scientists considered lignin - the woody structural component of plant cell walls - to be indigestible by cattle. Sugarcane bagasse (the fibrous residue left after sugar extraction) contains high lignin content, making it unsuitable as animal feed despite being available in massive quantities.
Impact Fusion's Innovation: A proprietary process that depolymerizes lignin, making it digestible and nutritionally valuable for cattle. This unlocks the energy potential in millions of tons of agricultural waste.
SGP+ (SUPREME GOLD PLUS) - THE FLAGSHIP PRODUCT:
A green, renewable cattle feed utilizing a proprietary blend of sugarcane bagasse and Nutri-Mastic (enriched mastic gum with ionic minerals).
Key Attributes:
- Cost: $150 per ton
- Feed Ratio: 80% SGP+ / 20% traditional feed
- Packaging: 2,200 lb wrapped bales or 700 lb SuperSax
- Distribution: 46,000 lb flatbed or railroad container to US, Canada, Mexico
- Production Capacity: 4,900 tons per week (6-day schedule, 2 shifts)
- Regulatory: All ingredients FDA and USDA approved
The Benefits: Why Ranchers Are Switching
| Benefit Category | Impact | Timeline |
|---|---|---|
| Cost Reduction | 85% savings reported by customers $3.45 to $0.45 per head/day |
Immediate |
| Fly Elimination | Up to 100% reduction in flies Significant odor reduction |
16-20 days |
| Herd Health | Enhanced estrous cycles Improved progeny health Better meat integrity Reduced antibiotic use |
30-90 days |
| Manure Quality | Ideal Score 3 manure patties Better pasture health |
Ongoing |
| Environmental | Reduced methane emissions Converts waste to value |
Long-term |
| Weight Gain | Faster weight gain from improved digestion | 60-120 days |
The Science Behind It
Dr. Bagley of SUARC, with 43 years of research experience in this field, testified to the Louisiana State Legislature that SGP+ represents the "Holy Grail" of unlocking lignin energy. The scientific backing is critical:
- University Validation: SUARC conducting 3-month research study on bagasse improvements
- Field Trials: Multiple Texas ranches reporting consistent results
- Government Recognition: Louisiana HCR-42 legislative support validates technology
Multiple Applications Beyond Cattle Feed
The lignin depolymerization technology has potential applications beyond cattle feed:
- Soil Amendment & Mulch: Improved soil health for agriculture
- Natural Insecticide: Fly management and insect repellent
- Greenhouse Gas Reduction: Methane emission credits
- Manure Management: Environmental compliance solutions
- Viticulture Applications: Wine industry uses
The Assets: What You're Actually Buying
Asset #1: SGP+ Technology & Production Capacity
Current Status: Producing and selling SGP+ to ranchers across multiple states. Production capacity of 4,900 tons per week represents ability to supply significant portion of U.S. cattle industry.
PRODUCTION METRICS:
- Weekly Capacity: 4,900 tons
- Annual Capacity: 254,800 tons (52 weeks)
- Potential Revenue at $150/ton: $38.2 million annually at full capacity
- Raw Material: Abundant sugarcane bagasse from Louisiana refineries
Total Asset Summary
TOTAL ASSET VALUATION:
| Asset | Conservative Value | Optimistic Value |
|---|---|---|
| SGP+ Production Capacity | $10M (25% utilization annual revenue) | $38M (full capacity annual revenue) |
| Intellectual Property Portfolio | $5M (AIT patent, processes) | $15M (if validated commercially) |
| Other Product Lines | $1M (Nutri-Mastic, supplements) | $5M (if scaled) |
| TOTAL ASSET VALUE | $16M+ | $58M+ |
| Current Market Cap | $19.8M | |
Asset #2: Intellectual Property Portfolio
- AIT (Artificial Insemination Technology): Patent-pending filed October 2025. Addresses $3.42B global cattle breeding market.
- Nutri-Mastic: Proprietary formulation combining mastic gum with ionic minerals for digestive health
- SGP+ Process: Lignin depolymerization methodology - the core technology unlocking agricultural waste
- Product Line: Intact Nutrition, Pet Intact, Equine Intact, Mastic Blast beverages
Asset #3: Other Products & Potential Revenue Streams
| Product | Market | Status |
|---|---|---|
| Nutri-Mastic | Human digestive health | Available |
| Intact Nutrition | Herbal health support | Available |
| Intact Endurance | Energy optimization | Available |
| Pet Intact | Pet supplements | Available |
| Equine Intact | Horse nutrition | Available |
| Mastic Blast | Herbal beverages | Available |
| AIT Technology | Cattle breeding ($3.42B global market) | Patent pending |
THE ASSET VALUE PROPOSITION:
You are buying a company with $16M-$58M in identifiable assets for a $19.8M market cap. Even in the conservative scenario with SGP+ achieving only 25% capacity utilization ($10M annual revenue), you're buying significant production capacity and IP at roughly market cap value.
In the optimistic scenario with SGP+ at full capacity ($38M revenue potential), you're acquiring $58M in assets for $19.8M.
The market is pricing IFUS as if the technology doesn't work. If even ONE component (SGP+) validates at half of stated value, the stock should re-rate significantly higher.
Financial Position: Lean and Early-Stage
Key Metrics (as of December 13, 2025)
FINANCIAL SNAPSHOT:
- Stock Price: $0.0340
- Market Cap: $19.8 million
- 52-Week High: $0.121 (256% above current)
- 52-Week Low: $0.0238 (43% below current)
- Average Volume (3M): 246,900 shares
- Total Cash: $15,020
- Total Debt: $640,830
- EPS (TTM): -$0.01
- P/S Ratio: 501.01 (pre-revenue stage distortion)
Balance Sheet Snapshot
| Assets | Conservative | Optimistic |
|---|---|---|
| Cash | $15,020 | $15,020 |
| SGP+ Production Assets | $10,000,000 | $38,000,000 |
| Intellectual Property | $5,000,000 | $15,000,000 |
| Other Assets | $1,000,000 | $5,000,000 |
| Total Assets | $16,015,020 | $58,015,020 |
| Liabilities | Amount |
|---|---|
| Total Debt | $640,830 |
| Total Liabilities | $640,830 |
Historical Revenue (Old Water Business)
IFUS was formerly Red Reef Laboratories and operated a water bottling/ice business. Limited historical revenue data:
| Year | Revenue | Change |
|---|---|---|
| 2009 | $24,936 | Baseline |
| 2010 | $9,893 | -60.33% |
Current Revenue: Early commercialization phase with SGP+ sales to ranchers. Specific revenue figures not disclosed in recent filings but customer testimonials indicate growing adoption.
The Debt Structure
Unlike many OTC companies drowning in toxic convertible debt, IFUS has a relatively clean balance sheet:
- Total Debt: $640,830 (significantly reduced from prior years)
- No Toxic Convertibles: Limited risk
- Debt Reduction History: Company has actively reduced debt over time
- Patient Capital: Development funded through equity, not high-interest debt
Valuation Context
Traditional valuation metrics don't apply well to early-stage biotech/agriculture companies. The investment case rests on:
- Technology validation (customer testimonials showing 85% cost savings)
- Scientific backing (SUARC, Louisiana Legislature, Dr. Bagley endorsement)
- Market need (drought, high feed costs, low cattle inventory)
- Production capacity (4,900 tons/week = $38M+ annual potential at $150/ton)
- Partnership momentum (India, SUARC, government support)
THE VALUATION DISCONNECT:
If IFUS achieves even 25% of its 4,900 ton/week production capacity and sells SGP+ at $150/ton, that's $9.5M in annual revenue - roughly half the current market cap, recurring.
The market is pricing IFUS as if the technology doesn't work. If this assumption proves wrong, substantial re-rating is possible.
Market Opportunity: Perfect Storm in Agriculture
The Cattle Feed Crisis
Multiple factors are converging to create unprecedented demand for innovative feed solutions:
| Market Driver | Impact | Opportunity for SGP+ |
|---|---|---|
| Drought Conditions | U.S. cattle inventory at decades-low Traditional feed prices soaring |
Alternative feed at $150/ton vs. $500+ for hay |
| Wildfire Destruction | 1.1M+ acres Texas grazing land destroyed 9.35M cattle affected |
Emergency feed solution needed immediately |
| Feed Cost Pressure | Feed = 60%+ of ranching expenses Margins crushed by inflation |
85% cost reduction = survival for ranchers |
| Environmental Regulation | Methane emission limits coming ESG pressure increasing |
Proven methane reduction with SGP+ |
| Waste Problem | Millions of tons bagasse waste annually Environmental disposal costs |
Waste-to-value conversion |
India Market Potential
IFUS has ongoing discussions with Indian partners who control:
- 10 Sugar Refineries: Access to massive bagasse supply for SGP+ 2.0 production
- 500,000+ Dairy Cattle: Immediate customer base
- National Dairy Development Board: Government connections for market entry
- Sumul Dairy: Major cooperative with millions of farmers
If India deal closes, it could dwarf the U.S. market in scale. India has the world's largest cattle population and growing dairy industry.
The Investment Thesis
Why IFUS Offers Extraordinary Asymmetric Risk/Reward:
- Technology Validation: 85% cost savings reported by actual customers, not projections. SUARC research backing. Louisiana Legislature unanimous support (99-0, 31-0). This isn't vaporware.
- Market Timing: Cattle feed crisis (drought, fires, high costs) creating immediate need.
- Production Capacity: 4,900 tons/week capacity already in place. This isn't a concept - equipment exists and is producing.
- Multiple Revenue Streams: SGP+ (cattle), Nutri-Mastic (humans), AIT (breeding), international expansion. Only ONE needs to hit big.
- Government Support: Louisiana HCR-42 legislation validates technology at state level. USDA grant interest indicates federal awareness.
- Low Cost Basis: At $0.0340, downside is capped (can't go below zero) while upside is exponential if execution delivers.
- Lean Operation: 4 employees means low burn rate. Not bloated with overhead while trying to prove concept.
The Simple Math
SCENARIO ANALYSIS:
Bear Case ($0.01/share):
- Market Cap: $5.6 million
- Implies: Technology fails, partnerships collapse
- Return from $0.0340: -71%
Conservative Case ($0.08/share):
- Market Cap: $44.8 million
- Implies: SGP+ generates $5-10M annual revenue
- Return from $0.0340: 135%
Base Case ($0.15/share):
- Market Cap: $84 million
- Implies: SGP+ hits $15-20M revenue, India progress
- Return from $0.0340: 341%
Bull Case ($0.50/share):
- Market Cap: $280 million
- Implies: SGP+ dominates regional market, India deal closes
- Return from $0.0340: 1,371%
Even the conservative case delivers 135% returns. Base case is 341%. Bull case is 14x. The asymmetry exists because downside is maybe 50-70% (company has real assets and technology) while upside is exponential if even partial execution occurs.
What Has to Go Right
For the investment thesis to work, IFUS needs to deliver on:
- SGP+ Sales Growth: Continue customer acquisition, prove consistency of results
- SUARC Results: Positive research findings validating technology scientifically
- Production Ramp: Increase from current levels toward 4,900 ton/week capacity
- Partnership Execution: India deal closure or other major customer wins
- Financial Stability: Maintain operations without massive dilution
These are achievable milestones, not pie-in-the-sky hopes. Company already has production capacity, paying customers, and institutional backing (SUARC, Legislature). Execution risk is real but not insurmountable.
Technical Analysis
TECHNICAL SIGNALS:
- Stock in lower range of falling trend
- Support level: $0.0317
- Resistance: $0.0349 and $0.0403
- 52-week range: $0.0238 - $0.121
Note: Technical analysis is less relevant for early-stage biotech/agriculture where fundamentals and catalysts drive price more than charts. The "Strong Sell" signal may reflect past underperformance, not future potential.
The Bottom Line
Impact Fusion International represents a rare convergence of factors that could create substantial returns for risk-tolerant speculators:
DOWNSIDE CASE: Technology fails to gain traction, ranchers reject SGP+, capital dries up, management can't execute. Stock goes to $0.005 or lower. You lose 50-85% of investment. This is a real possibility with any OTC biotech play.
BASE CASE: SGP+ sales grow to $15-20M annually as drought continues and word-of-mouth spreads. SUARC validates technology. Stock reaches $0.08-$0.15 range (135-341% returns).
BULL CASE: SGP+ becomes dominant alternative feed in multiple states. India deal closes opening massive international market. Market cap reaches $200-500M. Stock hits $0.35-$0.90 (929-2,547% returns).
What Makes This Different from Typical OTC Scams?
- Real Product: SGP+ is being produced and sold NOW. Customers exist and are reporting results.
- Scientific Validation: SUARC research partnership with Dr. Bagley (43 years experience) is verifiable.
- Government Support: Louisiana HCR-42 passed unanimously in both chambers. This is public record.
- Tangible Assets: Production facility exists.
- Customer Testimonials: Ranchers across multiple states confirming cost savings and herd improvements.
- Clean Restart: Moved away from old water business, focused on high-value agricultural innovation.
Is this bulletproof? No. Could it still fail? Absolutely. But it has MORE substance than 95% of OTC promotions that are pure share-selling schemes with no real products.
The Core Question
Is a company with proven technology showing 85% cost savings, university research backing, government support, and production capacity of 4,900 tons/week worth more than $19.8M?
If your answer is YES, then IFUS at current prices offers extraordinary asymmetric upside.
If your answer is NO (because you don't trust management, don't believe in the technology, or think execution risk is too high), then pass on this entirely.
Final Thoughts
At $0.0340 per share, IFUS is priced as if SGP+ doesn't work. Maybe the market is right. Maybe rancher adoption stalls. Maybe capital dries up.
But if management delivers even 50% of what they're promising - SGP+ revenue growth, SUARC validation, India progress - this stock should trade multiples higher.
The asymmetry is real. The risks are substantial. The opportunity is there for those willing to bet on agricultural innovation in an OTC wrapper.
The window for speculative entry is now, before SUARC results and production numbers prove or disprove the thesis.
How DDAmanda Finds Opportunities Like This
This research represents the type of deep-dive analysis we conduct on overlooked opportunities in the market. At DDAmanda, we've been identifying unusual stock movements and undervalued companies since 1999 using proprietary screening technology.
Our system tracks:
- Unusual dollar volume activity - Spotting institutional accumulation before the crowd
- Factor indicators - Quantitative signals that historically precede major runs
- Beaten-down stocks - Companies trading at significant discounts to intrinsic value
- The Munson Strategy - Our proprietary methodology for timing entries and exits
Whether you're looking for small-cap value opportunities, emerging biotech stories like Impact Fusion, or penny stock momentum plays, DDAmanda's screening system helps cut through the noise to find stocks with asymmetric risk/reward profiles.
"Your program is the best tool I've ever used in the past 21 years."
- Member Review
"I found CXCQ with DDAmanda. I'm up almost $100,000 on paper. DDAmanda probably pays for itself. ;)"
- Member Review
Ready to Find Your Next 10-Bagger?
Learn More About DDAmandaJoin traders who've been using DDAmanda since 1999 to find hidden gems before Wall Street.
DISCLAIMER & RISK DISCLOSURE
Not Investment Advice: This is educational content only. Not a recommendation to buy or sell. IFUS is a high-risk investment.
Do Your Own Work: We haven't independently verified all claims. All projections are speculative and may not happen. Consult a licensed financial advisor before investing. Never invest money you can't afford to lose completely.
Our Position: We may hold positions in IFUS and will sell to make a profit without notice. DDAmanda received no compensation from the company for this report.
Risk Warning: IFUS is a micro-cap OTC Pink sheet stock with extreme volatility and risk. Past performance does not guarantee future results. The company could fail, file for bankruptcy, or become worthless. Only invest what you can afford to lose completely.
Total Views: 176
Unique Visitors: 88